Oral presentation at ASCO to highlight topline Phase 2 data of elraglusib in combination with gemcitabine/nab-paclitaxel (GnP ...

That is below the 30% rate reported at an interim stage of the study at the International Liver Congress earlier this year, but still sufficient for GSK to take the drug forward into a phase 3 ...

GlaxoSmithKline has agreed a $3.3 billion takeover of US biotech Affinivax ... years has been dominated by Pfizer's Prevnar franchise. GSK said it is paying $2.1 billion upfront for Cambridge ...

iOS 18.5 Developer Beta 3 fixes a black screen issue in Vision Pro app The Mail app gets a quick shortcut for toggling Contact Photos Apple also released iOS 18.5 Public Beta 2 update for iPhone ...

In between, we can expect two or three more beta builds. Apple also released iPadOS 18.5 Beta 3, watchOS 11.5 Beta 3, macOS Sequoia 15.5 Beta 3, macOS Sonoma 14.7.6 RC2, macOS Ventura 13.7.6 RC2, tvOS ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. After seeding the second beta of iOS 18.5, Apple follows the testing cycle with beta 3.

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck ...

Battery performance in macOS 15.5 Beta 3 presents a mixed picture. While some users may observe slight improvements in power efficiency, overall battery life remains inconsistent. Resource ...

(NASDAQ: ACTU) ("Actuate” or the "Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the ...

Apple has released iOS 18.5 beta 3 for developers. The pre-release iPhone and iPad software update has been light on features, although there are some small changes. Changes so far include tweaks ...

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...